Back to Journals » Therapeutics and Clinical Risk Management » Volume 11

Integrating risk minimization planning throughout the clinical development and commercialization lifecycle: an opinion on how drug development could be improved
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
15,111 | Dovepress* | 12,057 | 1,436+ | 2,178 | 13,493 |
PubMed Central* | 0 | 1,618 | 426 | 1,618 | |
Totals | 12,057 | 3,054 | 2,604 | 15,111 | |
*Since 26 February 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar